For antibody manufacturers using hybridoma cell lines 

Enhance yield and cost-effectiveness in hybridoma cell growth and antibody production 

As a company that demands antibody manufacturing excellence, YEX™ can be effortlessly integrated into your workflows, replacing FBS and offering a suite of advantages that elevate efficiency, drive cost-effectiveness, and uphold unwavering quality.

Contact the YEX™ Team to elevate your cell growth strategies and connect with our experts to discuss how YEX™ aligns with your unique needs!

Choose the category that applies to you:

Biosimilar
manufacturers 

Learn more

Originator biologic
manufacturers 

Learn more

By unlocking the full potential of specialized cell types, YEX™ fuels innovation across diverse biotechnological horizons.

Monoclonal antibody production

Regenerative medicine

Virus production

Drug discovery and screening

Clinical diagnostics

Recombinant protein production